Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02583477
Title Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors AstraZeneca

pancreatic ductal adenocarcinoma


AZD5069 + Durvalumab

Durvalumab + Gemcitabine + Nab-paclitaxel

Age Groups: adult
Covered Countries USA

No variant requirements are available.